International experts in IBD met in Oxford at the 241^st Falk Foundation Symposium “Mucosal Immunology Days” to examine how clinical and research insights can better align in classifying IBD.  The Falk News provides summaries of selected presentations from this symposium and include a compelling interview with Prof. Britta Siegmund (Berlin, Germany).

The following talks are summarized in this Falk News:

• Prof. Fiona Powrie (Oxford, UK): A vision for IBD: Bridging basic research and clinical practice
• Prof. Matthie Allez (Montreal, Canada): Biological classification of IBD is complex
• Prof. Eoin McKinney (Cambridge, UK): Aging and the role of the immune system
• Prof. Derek Jewell (Oxford, UK): Disease location: What distiguisehes CD from UC?
• Prof. Carl Weidinger (Berlin, Germany): Focus on an extreme phenotype of IBD
• Prof. Hannah Gordon (Oxford, UK): Extrintestinal manifestations (EMI) in IBD
• Prof. Christopher Buckley (Oxford, UK): Gut and jo8int inflammation – two locations, one disease?
• Prof. Ibrahim Al Bakir (London, UK): Managing risks of colectoral cancer in IBD patients.